3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Prostatic Neoplasms
3
Leukemia
3
Hematologic Neoplasms
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Lymphoma, B-Cell
2
Lung Neoplasms
2
Carcinoma in Situ
2
Burkitt Lymphoma
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Sleep Initiation and Maintenance Disorders
1
Recurrence
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Peritoneal Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Nose Neoplasms
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Interventions
ruxolitinib
4
ponatinib
4
nilotinib
4
Imatinib Mesylate
4
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
2
sonidegib
1
simtuzumab
1
pembrolizumab
1
ibrutinib
1
bosutinib
1
Zoledronic Acid
1
Denosumab
1
CPI-0610
1
BID protein, human
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Bone Marrow Diseases
×
Electrocardiography
×
Clear all
No trials found.